PMID: 6111301Mar 1, 1981Paper

Tritiated LSD binding in frontal cortex in schizophrenia

Archives of General Psychiatry
P M WhitakerI N Ferrier

Abstract

It has been reported that the binding of tritiated LSD (at 2 or 4 nm) to frontal cortex is reduced in schizophrenia, a finding that has been interpreted as a reduction in the number of serotonin receptors. The present study, however, reveals in a Scatchard analysis of tritiated LSD binding in frontal cortex in the brains of 13 schizophrenic patients that there was no decrease in binding by comparison with eight control brains. Quantities of neuroleptic remaining in the brain after death cannot be readily washed out and could have led to the previous report of reduced LSD binding. A decrease in affinity of LSD binding sites consistent with this possibility has been demonstrated in chlorpromazine-treated rats. In the brains of five patients who had probably been neuroleptic-free for the year before death, tritiated LSD binding was significantly increased. This result needs to be replicated in larger samples.

Citations

Nov 28, 2012·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Carolina MuguruzaJavier González-Maeso
Jan 1, 1991·Journal of Neural Transmission. General Section·R C Arora, H Y Meltzer
Feb 1, 1982·Psychological Medicine·R M Ridley, H F Baker
Mar 1, 1997·Journal of Psychiatric Research·J F Deakin, M D Simpson
Sep 12, 2000·Psychiatry Research·P GovitrapongA Srikiatkhachorn
May 1, 1993·Psychiatry Research·R C Arora, H Y Meltzer
Dec 4, 1998·Biological Psychiatry·J A LiebermanJ E Kraus
Mar 1, 1992·Biological Psychiatry·H S LeeH Y Meltzer
Sep 18, 1996·Schizophrenia Research·B Dean, W Hayes
Jan 1, 1996·Behavioural Brain Research·B DeanD L Copolov
Jul 12, 2011·Expert Opinion on Investigational Drugs·Bjørn H EbdrupBirte Glenthøj
Sep 3, 1999·Biological Psychiatry·J C Soares, R B Innis
Jul 12, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Teresa M du BoisXu-Feng Huang
Aug 12, 2008·Schizophrenia Research·Brian DeanElizabeth Scarr
Mar 14, 2007·International Review of Neurobiology·Anissa Abi-Dargham
Aug 23, 2000·The Australian and New Zealand Journal of Psychiatry·B Dean
Oct 10, 2007·Harvard Review of Psychiatry·W Gordon Frankle
Jan 1, 1997·Journal of Psychopharmacology·F W DeakinJ S Hellewell
Feb 22, 2008·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·David ErritzoeBirte Y Glenthoj
May 1, 1985·The British Journal of Psychiatry : the Journal of Mental Science·F OwenH W Kosterlitz
Nov 1, 1988·Psychological Medicine·G P Reynolds

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

© 2021 Meta ULC. All rights reserved